Loading data
GXAINasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 1.93 m USD | 4.03 k USD | 256 USD | — |
| Research and development expense | 993.67 k USD | 996.49 k USD | 915.82 k USD | 824.52 k USD |
| Operating profit | -4.92 m USD | -3.7 m USD | -4.02 m USD | -1.42 m USD |
| Net income (reported basis) | -3.9 m USD | -3.42 m USD | -3.95 m USD | -1.42 m USD |
| Basic earnings per share | -0.55 USD/share | -1.92 USD/share | -3.9 USD/share | -1.64 USD/share |
| Diluted earnings per share | -0.55 USD/share | -1.92 USD/share | -3.9 USD/share | -1.64 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.